NIO Inc. Provides July 2020 Delivery Update
NIO delivered 3,533 vehicles in July 2020, increasing by 322.1% year-over-yearNIO delivered 17,702 vehicles in 2020 in total, increasing by […]
Bilibili Announces Three-Year Strategic Partnership with Riot Games for Live Broadcasting League of Legend Events in China
SHANGHAI, China, Aug. 03, 2020 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI), a leading online entertainment […]
ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical Officer
SINGAPORE, Aug. 03, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company […]
Atotech expands its software capabilities
BERLIN, Aug. 03, 2020 (GLOBE NEWSWIRE) — Today, Atotech, a leading global provider of specialty surface-finishing solutions, announced it has […]
TSX News -
Etrion to Release Second Quarter 2020 Results on August 6, 2020
GENEVA, Switzerland, Aug. 03, 2020 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar […]
Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million
NEW YORK and LONDON, Aug. 03, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ: TLSA; AIM: TILS) (the “Company” […]
Verona Pharma Announces August 2020 Virtual Investor Conference Participation
LONDON and RALEIGH, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a […]
VAALCO Schedules Second Quarter 2020 Earnings Release and Conference Call
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) today announced the timing of its […]
Global Care Capital Inc. CEO Provides Corporate Update
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Aug. 03, 2020 […]
Celyad Oncology to Announce First Half 2020 Financial Results and Host Conference Call
MONT-SAINT-GUIBERT, Belgium, Aug. 03, 2020 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused […]
